Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Coivas vs Ways2Well

Coivas
Graded #197

Higher grade

vs+13.300000000000004
Ways2Well
Graded #477

Lower grade

The verdict

Coivas takes it — 66.2/100 to 52.9/100.

Coivas grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Coivas is an all-inclusive GLP-1 telehealth service operated by WellVi LLC (d/b/a Coivas) with prescriptions through Arora Health & Aesthetics, LLC.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoivas +25
70
45
Dose & formulationCoivas +24
64
40
Clinical oversightCoivas +19
84
65
Labs & monitoringWays2Well +10
54
64
FulfillmentCoivas +23
78
55
Contract termsWays2Well +35
20
55
Coivas · left barWays2Well · right bar

The numbers

MetricCoivasWays2Well
WeighScore66.2/10052.9/100
GradeCC
Scorecard rank#197#477
Semaglutide$149/mo (quarterly plan, compounded)Not disclosed
Tirzepatide$229/mo (quarterly plan, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Coivas

Graded #197 · C

Strengths

  • All-inclusive pricing: one price covers doctor consult, prescription, shipping and support
  • Compounded semaglutide from $149/mo and tirzepatide from $229/mo on the quarterly plan
  • Names its clinical provider (Arora Health & Aesthetics, LLC) and cites USP 797 / NABP-accredited pharmacies
  • Available in all 50 states; 24/7 support; HSA/FSA eligible; money-back guarantee
  • Most patients approved in under 2 hours; refund if no provider visit or prescription occurs

Where it loses points

  • Dispensing pharmacies described only by category (503A/503B, NABP-accredited) - not named individually
  • Lower quarterly headline price requires a 3-month commitment; monthly plan costs more ($179/$289)
  • Money-back guarantee has strict adherence/verification conditions and no partial/prorated refunds
  • No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only; binding NY arbitration
Ways2Well

Graded #477 · C

Strengths

  • Lab-based, clinician-directed care with bloodwork and biomarker tracking
  • Compounded GLP-1 filled by its named sister pharmacy, ReviveRX
  • Established brand with a named founder (Brigham Buhler) and its own patient app

Where it loses points

  • GLP-1 weight-loss pricing is not published on the live site and is gated behind membership
  • State coverage is limited and not fully listed
  • Requires a membership and clinician protocol rather than a simple standalone GLP-1 plan

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard